NCT01568788 - Post-marketing Clinical Observation of an Inactivated Influenza Split Vaccine | Biotech Hunter

Enrollment

600

Participants

Timeline

Start Date

December 31, 2008

Primary Completion Date

January 31, 2009

Study Completion Date

March 31, 2009

Conditions

Human Influenza

Interventions

BIOLOGICAL

Inactivated Influenza Vaccine

200 subjects were randomly assigned (60 children, 100 adults and 40 elders) to receive Inactivated Influenza Vaccine (Split virion) of Hualan Biologicals, 15ug HA/strain/0.5ml/syringe, one dose regime

BIOLOGICAL

Inactivated Influenza Vaccine of Pasteur

200 subjects (60 children, 100 adults and 40 elders) were randomly assigned to receive the Inactivated Influenza Vaccine of Sanofi Pasteur, 15ug HA/strain/0.5 ml/syringe, one dose regime,

BIOLOGICAL

Inactivated Influenza Vaccine of GSK

200 subjects (60 children, 100 adults and 40 elders) were randomly assigned to receive Inactivated Influenza Vaccine (Split virion) of GSK, 15ug HA/strain/0.5ml/syringe, one dose regime

Trial Locations (1)

621000

Yanting County, Mianyang